Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Health and Human Services airs views on cost recovery and stem cell research

This article was originally published in Clinica

Executive Summary

The US National Institutes of Health should recoup a portion of the revenues of pharmaceuticals it helps to develop, believes Health and Human Services secretary Tommy Thompson. In an interview with Washington Post, he said that the money gained could be used for a prescription drug purchasing programme. It is not known whether Mr Thompson also favours recouping the cost of developing advanced medical technology.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT071658

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel